2XLN
Crystal structure of a complex between Actinomadura R39 DD-peptidase and a boronate inhibitor
2XLN の概要
エントリーDOI | 10.2210/pdb2xln/pdb |
関連するPDBエントリー | 1W79 1W8Q 1W8Y 2VGJ 2VGK 2WKE 2XDM 2XK1 2Y4A 2Y55 2Y59 |
分子名称 | D-ALANYL-D-ALANINE CARBOXYPEPTIDASE,, [(1S)-1-{[(2,6-DIMETHOXYPHENYL)CARBONYL]AMINO}ETHYL]BORONIC ACID, SULFATE ION, ... (5 entities in total) |
機能のキーワード | hydrolase, peptidoglycan |
由来する生物種 | ACTINOMADURA SP |
細胞内の位置 | Secreted: P39045 |
タンパク質・核酸の鎖数 | 4 |
化学式量合計 | 203098.42 |
構造登録者 | Sauvage, E.,Herman, R.,Kerff, F.,Rocaboy, M.,Charlier, P. (登録日: 2010-07-21, 公開日: 2011-01-26, 最終更新日: 2014-06-18) |
主引用文献 | Woon, E.C.Y.,Zervosen, A.,Sauvage, E.,Simmons, K.J.,Ivec, M.,Inglis, S.R.,Fishwick, C.W.G.,Gobec, S.,Charlier, P.,Luxen, A.,Schofield, C.J. Structure Guided Development of Potent Reversibly Binding Penicillin Binding Protein Inhibitors Acs Med.Chem.Lett., 2:219-, 2011 Cited by PubMed Abstract: Following from the evaluation of different types of electrophiles, combined modeling and crystallographic analyses are used to generate potent boronic acid based inhibitors of a penicillin binding protein. The results suggest that a structurally informed approach to penicillin binding protein inhibition will be useful for the development of both improved reversibly binding inhibitors, including boronic acids, and acylating inhibitors, such as β-lactams. PubMed: 24900305DOI: 10.1021/ML100260X 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.4 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード